previous compound ID: 1753 next compound
InChIKey: PSGAAPLEWMOORI-PEINSRQWSA-N
SMILES: C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Liao" "B Kus" "GW Carlile" "J Goepp" "SD Macknight" "D Rotin" "DY Thomas" "JW Hanrahan" "E Matthes" "R Robert"

chemical graph of compound 1753





CID is 6279
synonyms found at PubChem are:
Medroxyprogesterone acetate, 71-58-9, Medroxyprogesterone 17-acetate, Metigestrona, Provera, Depo-Provera, Farlutin, Gestapuran, Perlutex, Veramix, Methylacetoxyprogesterone, Medroxyacetate progesterone, Depcorlutin, Deporone, Lutopolar, Nadigest, Prodasone, Progestalfa, Progevera, Proverone, Repromix, Sirprogen, Supprestral, Lutoral, Nidaxin, Oragest, Depo-Promone, Promone-E, Medrosterona, Clinofem, Cykrina, Depocon, Indivina, Mepastat, Meprate, Repromap, Sumiferm, Suprestral, Veraplex, Dugen, Provera dosepak, 6-alpha-Methyl-17-alpha-acetoxyprogesterone, Depo-progestin, Depo-Prodasone, Depo-Progevera, Depo-Ralovera, Perlutex Leo, Depo-Map, Aragest 5, Med-Pro, MPA-beta, MPA Hexal, MPA-Noury, 6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate, MAP (steroid), 17alpha-Hydroxy-6alpha-methylprogesterone acetate, 6alpha-Methyl-17alpha-hydroxyprogesterone acetate, Amen, MPA GYM, Depo-Medroxyprogesterone acetate, Depot-medroxyprogesterone acetate, Medroxyprogesteroneacetate, Depo-Subq Provera 104, UNII-C2QI4IOI2G, DP150, 17-Acetoxy-6alpha-methylprogesterone, NSC-26386, 6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate, Aragest, Clinovir, Medroxyprogesterone (acetate), Ralovera, 6alpha-Methyl-17-acetoxy progesterone, CCRIS 371, Hysron, Depo-clinovir, Depot medroxyprogesterone acetate, EINECS 200-757-9, 6alpha-Methyl-17-acetoxyprogesterone, NSC 21171, U 8839, C2QI4IOI2G, 17-Acetoxy-6-alpha-methylprogesterone, 6-alpha-Methyl-17-acetoxy progesterone, BRN 2066112, Depomedroxyprogesterone acetate, Medroxyprogesterone-17-acetate, AI3-60127, MLS000069442, (6alpha)-6-methyl-3,20-dioxopregn-4-en-17-yl acetate, CHEBI:6716, ONCO-Provera, Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6alpha)-, 17alpha-Hydroxy-6-alpha-methylprogesterone acetate, Progesterone, 17-hydroxy-6alpha-methyl-, acetate, 17-alpha-Hydroxy-6-alpha-methylprogesterone acetate, 6alpha-Methyl-17alpha-acetoxypregn-4-ene-3,20-dione, 17-alpha-Acetoxy-6-alpha-methylpregn-4-ene-3,20-dione, 17alpha-Acetoxy-6-alpha-methylpregn-4-ene-3,20-dione, 6-alpha-Methyl-17-alpha-acetoxypregn-4-ene-3,20-dione, Progesterone, 17-alpha-hydroxy-6-alpha-methyl-, acetate, Medroxyprogesterone acetate [Progestins], (6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione, 17-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione acetate, 6-alpha-Methyl-4-pregnene-3,20-dion-17-alpha-ol acetate, (6-alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione, 17alpha-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione acetate, 6alpha-Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, CPD000653524, SMR000059125, 17-alpha-Hydroxy-6-alpha-methylpregn-4-ene-3,20-dione acetate, DSSTox_CID_5527, DSSTox_RID_77819, DSSTox_GSID_25527, [(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate, 17alpha-Acetoxy-6alpha-methylprogesterone, Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6a)-, (6-alpha)-Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, Depo-subq provera, CAS-71-58-9, 17.alpha.-Acetoxy-6.alpha.-methylprogesterone, Depo-Provera Contraceptive, (6.alpha.-Pregn-4-ene-3, 17-(acetyloxy)-6-methyl-, 17.alpha.-Hydroxy-6-.alpha.-methylprogesterone acetate, Pregn-4-ene-3, 17-hydroxy-6.alpha.-methyl-, acetate, Pregn-4-ene-3, 17-(acetyloxy)-6-methyl-, (6.alpha.)-, Progestins, medoxyprogesterone, Medroxyprogesterone acetate [JAN], 17-Acetoxy-6.alpha.-methylprogesterone, 6.alpha.-Methyl-17-acetoxyprogesterone, NCGC00094713-01, Provera (TN), Depo-provera (TN), Medroxyprogesterone acetate [USP:JAN], 6.alpha.-Methyl-17.alpha.-acetoxyprogesterone, PubChem13062, Depo-ProveraContraceptive, Opera_ID_1110, 17.alpha.-Hydroxy-6.alpha.-methylprogesterone acetate, 6.alpha.-Methyl-17.alpha.-hydroxyprogesterone acetate, Medroxiprogesterone Acetate, CHEMBL717, AC1L1M6L, SCHEMBL4276, 6.alpha.-Methyl-17.alpha.-acetoxypregn-4-ene-3,20-dione, 17.alpha.-Acetoxy-6-.alpha.-methylpregn-4-ene-3,20-dione, 4-08-00-02212 (Beilstein Handbook Reference), 6-alpha-Methyl-17alpha-hydroxyprogesterone Acetate, 6.alpha.-Methyl-4-pregnene-3,20-dion-17.alpha.-ol acetate, MLS001148217, MLS002207115, 17.alpha.-Hydroxy-6.alpha.-methylpregn-4-ene-3,20-dione acetate, Depo-subq provera 104 (TN), DTXSID0025527, PREMPRO (PREMARIN;CYCRIN), MolPort-001-794-638, PSGAAPLEWMOORI-PEINSRQWSA-N, HMS2233O07, HMS2235E05, HMS3259O14, Medroxyprogesterone 17-acetate;MPA, (6S,8R,9S,10R,13S,14S,17R)-17-Acetyl-6,10,13-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate, HY-B0469, KS-00001F8G, NSC21171, NSC26386, ZINC5029557, Tox21_111319, Tox21_200141, BDBM50067678, CM0089, NSC-21171, s2567, AKOS015894870, Tox21_111319_1, AC-2174, CS-2583, DB00603, LS-1607, NC00574, Medroxyprogesterone acetate (JP17/USP), MRF-0000023, NCGC00022037-03, NCGC00022037-04, NCGC00022037-05, NCGC00022037-07, NCGC00257695-01, NCGC00263480-01, AN-14229, AS-13981, CC-30186, I028, SAM002564220, SMR000653524, AB2000663, PREMPHASE (PREMARIN;CYCRIN 14/14), C08150, D00951, 16534-EP2269990A1, 16534-EP2272517A1, 16534-EP2275102A1, 16534-EP2275413A1, 16534-EP2281563A1, 16534-EP2281815A1, 16534-EP2287156A1, 16534-EP2289893A1, 16534-EP2289894A2, 16534-EP2295550A2, 16534-EP2298731A1, 16534-EP2298743A1, 16534-EP2298768A1, 16534-EP2301933A1, 16534-EP2305640A2, 16534-EP2308861A1, 16534-EP2311807A1, 16534-EP2311827A1, 16534-EP2314574A1, 16534-EP2316459A1, 92480-EP2295416A2, 92480-EP2295426A1, 92480-EP2295427A1, 92480-EP2298748A2, 92480-EP2298768A1, 92480-EP2305642A2, AB00384270-14, AB00384270_15, Medroxyprogesterone 17-acetate, >=97% (HPLC), 010M483, C-21458, (6?)-6-Methyl-3,20-dioxopregn-4-en-17-yl acetate, 6.alpha.-Pregn-4-ene-3, 17-(acetyloxy)-6-methyl-, P097000000, Pregn-4-ene-3,20-dione, 17-hydroxy-6alpha-methyl-, acetate, Medroxyprogesterone 17-acetate, VETRANAL(TM), analytical standard, Medroxyprogesterone acetate, European Pharmacopoeia (EP) Reference Standard, Pregn-4-ene-3,20-dione, 17-hydroxy-6alpha-methyl-, acetate (8CI), Medroxyprogesterone Acetate, Pharmaceutical Secondary Standard; Certified Reference Material, Medroxyprogesterone acetate, United States Pharmacopeia (USP) Reference Standard, Medroxyprogesterone acetate for peak identification, European Pharmacopoeia (EP) Reference Standard, Medroxyprogesterone acetate for system suitability, European Pharmacopoeia (EP) Reference Standard, Medroxyprogesterone acetate, for performance test, European Pharmacopoeia (EP) Reference Standard